Global Gastric Cancer Market

Global Gastric Cancer Market Trend and Development Strategy Analysis 2023-2029

Global Gastric Cancer Market

Global Gastric Cancer Market Trend and Development Strategy Analysis 2023-2029

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Market Analysis and Insights: Global Gastric Cancer Market

The global Gastric Cancer market size in 2022 is 2300.0 million US dollars, and it is expected to be 6900.0 million US dollars by 2029, with a compound annual growth rate of 17.60% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:

The main players in the Gastric Cancer market include Novartis AG, Pfizer, Inc., Viatris, Inc. (Mylan N.V.), F. Hoffmann-La Roche Ltd., and Eli Lilly And Company. The share of the top 3 players in the Gastric Cancer market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Gastric Cancer market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. Adenocarcinoma accounted for XX% of Gastric Cancer market in 2022. Carcinoid Tumor share of XX%.

Specialty & Retail Pharmacies accounted for XX% of the Gastric Cancer market in 2022. Hospital Pharmacies accounts for XX%.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gastric Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gastric Cancer market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gastric Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gastric Cancer market.

Global Gastric Cancer Scope and Market Size

Gastric Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastric Cancer market will be able to gain the upper hand as they use the report as a powerful resource.

The impact of the outbreak of COVID-19 and the Russia-Ukraine War on the Gastric Cancer industry is considered in the report, covering the dynamic analysis of the development of the Gastric Cancer industry, including trends, technologies, opportunities, constraints. To ensure report buyers are able to gain in-depth knowledge of the market.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Key Regions Covered in This Report Are

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Spain

Nordic

Asia Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

Egypt

South Africa

UAE

Turkey

Saudi Arabia

Some of the major players operating in the global market include:

Novartis AG

Pfizer, Inc.

Viatris, Inc. (Mylan N.V.)

F. Hoffmann-La Roche Ltd.

Eli Lilly And Company

Merck & Co., Inc.

Teva Pharmaceuticals Industries Ltd.

Bristol Myers Squibb Company

Celltrion Healthcare Co., Ltd.

Samsung Biologics Co., Ltd. (Samsung Bioepis Co., Ltd.)

Segment by Type

Adenocarcinoma

Carcinoid Tumor

Gastrointestinal Stromal Tumor

Lymphoma

Others

Application list

Specialty & Retail Pharmacies

Hospital Pharmacies

Others


Key Highlights of the Report:

  • Market Performance (2016-2021)

  • Market Outlook (2022-2028)

  • Market Trends

  • Market Drivers and Success Factors

  • Impact of COVID-19

  • Value Chain Analysis

  • Comprehensive mapping of the competitive landscape

Table of Content

1 Gastric Cancer Market Introduction and Overview

1.1 Gastric Cancer Definition

1.2 Research Purposes

1.3 Report Timeline

1.4 Economic Analysis of Global Regions

1.5 Gastric Cancer Industry Dynamic Analysis

1.5.1 Gastric Cancer Market Trends Analysis

1.5.2 Gastric Cancer Market Drivers Analysis

1.5.3 Gastric Cancer Market Challenges Analysis

1.5.4 Gastric Cancer Market Restraints Analysis

1.6 Inflation Analysis

1.7 The Impact of the Russian-Ukrainian War on the Market

1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global

2 Global Gastric Cancer Market Insights by Type

2.1 Market Size Insights by Types

2.2 Global Gastric Cancer Revenue and Share by Type

3 Global Gastric Cancer Market Insights by Application

3.1 Market Size Insights by Application

3.2 Global Gastric Cancer Revenue and Share by Application (2018-2023)

4 Global Market Growth Insights

4.1 Global Gastric Cancer Market Size (2018-2023)

4.2 Gastric Cancer Growth Insights by Regions

4.2.1 Gastric Cancer Market Size by Regions: 2018 VS 2023 VS 2029

4.2.2 Gastric Cancer Revenue Market Size by Regions (2018-2023)

4.2.3 North America Gastric Cancer Market Size (2018-2023)

4.2.4 Europe Gastric Cancer Market Size (2018-2023)

4.2.5 Asia-Pacific Gastric Cancer Market Size (2018-2023)

4.2.6 Latin America Gastric Cancer Market Size (2018-2023)

4.2.7 Middle East & Africa Gastric Cancer Market Size (2018-2023)

5 North America

5.1 North America Gastric Cancer Revenue by Countries

5.1.1 North America Gastric Cancer Revenue by Countries (2018-2023)

5.2 North America PEST Analysis

5.3 United States

5.4 Canada

6 Asia Pacific

6.1 Asia Pacific Gastric Cancer Revenue by Countries

6.1.1 Asia Pacific Gastric Cancer Revenue by Countries (2018-2023)

6.2 Asia-Pacific PEST Analysis

6.3 China

6.4 Japan

6.5 Korea

6.6 Southeast Asia

6.7 India

6.8 Australia

7 Europe

7.1 Europe Gastric Cancer Revenue by Countries

7.1.1 Europe Gastric Cancer Revenue by Countries (2018-2023)

7.2 Europe PEST Analysis

7.3 Germany

7.4 France

7.5 UK

7.6 Italy

7.7 Russia

7.8 Spain

7.9 Nordic

8 Latin America

8.1 Latin America Gastric Cancer Revenue by Countries

8.1.1 Latin America Gastric Cancer Revenue by Countries (2018-2023)

8.2 Latin America PEST Analysis

8.3 Brazil

8.4 Argentina

8.5 Mexico

9 Middle East & Africa

9.1 Middle East & Africa Gastric Cancer Revenue by Countries

9.1.1 Middle East & Africa Gastric Cancer Revenue by Countries (2018-2023)

9.2 Middle East & Africa PEST Analysis

9.3 Egypt

9.4 South Africa

9.5 UAE

9.6 Turkey

9.7 Saudi Arabia

10 Global Gastric Cancer Market Competition, by Players

10.1 Global Gastric Cancer Revenue and Market Share by Players

10.2 Market Concentration Rate

10.2.1 Top 3 Gastric Cancer Players Market Share in 2022

10.2.2 Top 6 Gastric Cancer Players Market Share in 2022

10.2.3 Market Competition Trend

10.3 Gastric Cancer Players Head Office, Business Provided

10.4 Gastric Cancer Mergers & Acquisitions

10.5 Gastric Cancer New Entrants and Expansion Plans

11 Players Profiles

11.1 Novartis AG

11.1.1 Novartis AG Company Profile

11.1.2 Gastric Cancer Product Overview

11.1.3 Novartis AG Gastric Cancer Market Performance (2018-2023)

11.1.4 Novartis AG Business Overview

11.1.5 Recent Developments and Plans

11.2 Pfizer, Inc.

11.2.1 Pfizer, Inc. Company Profile

11.2.2 Gastric Cancer Product Overview

11.2.3 Pfizer, Inc. Gastric Cancer Market Performance (2018-2023)

11.2.4 Pfizer, Inc. Business Overview

11.2.5 Recent Developments and Plans

11.3 Viatris, Inc. (Mylan N.V.)

11.3.1 Viatris, Inc. (Mylan N.V.) Company Profile

11.3.2 Gastric Cancer Product Overview

11.3.3 Viatris, Inc. (Mylan N.V.) Gastric Cancer Market Performance (2018-2023)

11.3.4 Viatris, Inc. (Mylan N.V.) Business Overview

11.3.5 Recent Developments and Plans

11.4 F. Hoffmann-La Roche Ltd.

11.4.1 F. Hoffmann-La Roche Ltd. Company Profile

11.4.2 Gastric Cancer Product Overview

11.4.3 F. Hoffmann-La Roche Ltd. Gastric Cancer Market Performance (2018-2023)

11.4.4 F. Hoffmann-La Roche Ltd. Business Overview

11.4.5 Recent Developments and Plans

11.5 Eli Lilly And Company

11.5.1 Eli Lilly And Company Company Profile

11.5.2 Gastric Cancer Product Overview

11.5.3 Eli Lilly And Company Gastric Cancer Market Performance (2018-2023)

11.5.4 Eli Lilly And Company Business Overview

11.5.5 Recent Developments and Plans

11.6 Merck & Co., Inc.

11.6.1 Merck & Co., Inc. Company Profile

11.6.2 Gastric Cancer Product Overview

11.6.3 Merck & Co., Inc. Gastric Cancer Market Performance (2018-2023)

11.6.4 Merck & Co., Inc. Business Overview

11.6.5 Recent Developments and Plans

11.7 Teva Pharmaceuticals Industries Ltd.

11.7.1 Teva Pharmaceuticals Industries Ltd. Company Profile

11.7.2 Gastric Cancer Product Overview

11.7.3 Teva Pharmaceuticals Industries Ltd. Gastric Cancer Market Performance (2018-2023)

11.7.4 Teva Pharmaceuticals Industries Ltd. Business Overview

11.7.5 Recent Developments and Plans

11.8 Bristol Myers Squibb Company

11.8.1 Bristol Myers Squibb Company Company Profile

11.8.2 Gastric Cancer Product Overview

11.8.3 Bristol Myers Squibb Company Gastric Cancer Market Performance (2018-2023)

11.8.4 Bristol Myers Squibb Company Business Overview

11.8.5 Recent Developments and Plans

11.9 Celltrion Healthcare Co., Ltd.

11.9.1 Celltrion Healthcare Co., Ltd. Company Profile

11.9.2 Gastric Cancer Product Overview

11.9.3 Celltrion Healthcare Co., Ltd. Gastric Cancer Market Performance (2018-2023)

11.9.4 Celltrion Healthcare Co., Ltd. Business Overview

11.9.5 Recent Developments and Plans

11.10 Samsung Biologics Co., Ltd. (Samsung Bioepis Co., Ltd.)

11.10.1 Samsung Biologics Co., Ltd. (Samsung Bioepis Co., Ltd.) Company Profile

11.10.2 Gastric Cancer Product Overview

11.10.3 Samsung Biologics Co., Ltd. (Samsung Bioepis Co., Ltd.) Gastric Cancer Market Performance (2018-2023)

11.10.4 Samsung Biologics Co., Ltd. (Samsung Bioepis Co., Ltd.) Business Overview

11.10.5 Recent Developments and Plans

12 Global Gastric Cancer Forecast Market Insights by Type

12.1 Global Gastric Cancer Revenue Market Forecast by Type (2023-2029)

13 Global Gastric Cancer Forecast Market Insights by Application

13.1 Gastric Cancer Revenue Market Forecast by Application (2023-2029)

14 Global Market Growth Forecast Insights

14.1 Global Gastric Cancer Forecast Market Size (2023-2029)

14.2 Gastric Cancer Growth Forecast Insights by Regions

14.2.1 Gastric Cancer Revenue Forecast Market Size by Regions (2023-2029)

14.2.2 North America Gastric Cancer Forecast Market Size (2023-2029)

14.2.3 Europe Gastric Cancer Forecast Market Size (2023-2029)

14.2.4 Asia-Pacific Gastric Cancer Forecast Market Size (2023-2029)

14.2.5 Latin America Gastric Cancer Forecast Market Size (2023-2029)

14.2.6 Middle East & Africa Gastric Cancer Forecast Market Size (2023-2029)

15 Methodology and Data Source

15.1 A Methodology

15.1.1 Research Process

15.1.2 Market Size Estimation

15.1.3 Market Breakdown and Data Triangulation

15.2 B Data Source

15.2.1 Legal Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Global Gastric Cancer Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why are some of the most well-known companies left out of the Global Gastric Cancer Market study?
The Global Gastric Cancer study includes a diverse group of participants, including both market leaders and up-and-comers. Contact our sales representative to receive a complete list of companies covered in the study.
What are the major applications of the Global Gastric Cancer Market?
Depending upon the type of applications, the Global Gastric Cancer Market has been segmented into and other applications.
What is the estimated size & growth rate of the Global Gastric Cancer Market?
In recent years, the Global Gastric Cancer Market has grown at an incredible rate. From 2025 to 2030, the market is expected to grow at a CAGR of yy%.
What trends may have an impact on the Global Gastric Cancer Market's growth?
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the Global Gastric Cancer Market as well as its distribution among its players
How is the competitive landscape for the Global Gastric Cancer Market defined?
Companies in the Global Gastric Cancer Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Global Gastric Cancer Market's trajectory and future outlook.